Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a with or without tenofovir for HBeAg-positive chronic hepatitis B
ACTRN12610001101077Phase 4Recruiting
- Sponsor
- Dr Anouk Dev
- Start
- Jan 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2a and tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Dr Anouk Dev. Started Jan 2011; status: recruiting.
02
Drugs
peginterferon alfa-2atenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ACTRN12610001101077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001101077.